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Summary 
Thymic epithelial ceils play a crucial role in the selection of developing thymocytes. Thymocyte- 
epithelial  cell interactions involve a number of adhesion molecules, including members of the 
integrin and immunoglobulin  superfamilies. We found that human thymic epithelial cells synthesize 
an endogenous lectin, galectin-1, which binds to oligosaccharide ligands on the surface  of thymocytes 
and T  lymphoblastoid cells. Binding of T  lymphoblastoid cells to thymic epithelial cells was 
inhibited by antibody to galectin-1 on the epithelial cells, and by two antibodies, T305 and 2Bll, 
that recognize carbohydrate epitopes on the T  cell surface glycoproteins CD43  and CD45, 
respectively. T lymphoblastoid  ceils and thymocytes bound recombinant galectin-1, as demonstrated 
by flow cytometric analysis, and lectin binding was completely inhibited in the presence of lactose. 
The degree of galectin-1 binding to thymocytes correlated with the maturation stage of the cells, 
as immature thymocytes bound more galectin-1 than did mature thymocytes. Preferential binding 
of galectin-1  to  immature  thymocytes may  result  from  regulated  expression  of preferred 
oligosaccharide ligands on those cells, since we found that the epitope recognized by the T305 
antibody, the core 2 O-glycan structure on CD43, was expressed on cortical, but not medullary 
cells. The level of expression of the UDP-GIcNAc:Gal31,3GalNAc-R 31, 6GlcNAc transferase 
(core 2 31, 6 GlcNAc transferase, or C2GnT), which creates the core 20-glycan structure, correlated 
with the glycosylation change between cortical and medullary cells. Expression of mRNA encoding 
the C2GnT was high in subcapsular and cortical thymocytes and low in medullary thymocytes, 
as demonstrated by in situ hybridization. These results suggest that galectin-1  participates  in 
thymocyte--thymic epithelial cell interactions, and that this interaction may be regulated by expression 
of relevant oligosaccharide  ligands on the thymocyte cell surface. 
I 
nteraction between developing thymocytes and thymic ep- 
ithelial cells is an important step in the maturation of im- 
munocompetent T  ceils (reviewed in references  1 and 2). 
Thymic epithelial cells have been proposed to mediate posi- 
tive selection of thymocytes bearing the appropriate T  cell 
receptor and may also participate in negative selection,  or 
the induction of tolerance (3, 4). Several cell adhesion mole- 
cules on thymocytes and thymic epithelial cells have been 
identified, and some of these have been shown to participate 
in the binding of human thymocytes to epithelial cells in vitro, 
including the receptor-ligand pairs CD2 and LFA-3, and LFA-1 
and intercellular  adhesion molecule (ICAM) 1 (1, 2). Other 
adhesion molecules which have been identified on human 
thymic epithelial  cells include CD40,  CD23,  and 31 inte- 
grins (5-8).  It  has been proposed that different adhesion 
systems may be used at different points in thymocyte matu- 
ration, or by cells in different  pathways. 
In addition to the protein-protein interactions that mediate 
cell adhesion, a number of investigators  have suggested that 
carbohydrate-protein interactions may also be involved in the 
adhesion of thymocytes to thymic epithelium. An endoge- 
nous lectin, or carbohydrate binding protein, has been iden- 
tified in extracts of mouse and chicken thymic stroma (9-11). 
This lectin was identified as galectin-1  (previously  referred 
to as L14-I, galaptin, and IML-1),  a member of the family 
of S-type, cation-independent lectins (12-15). The galectins 
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tiaUy recognizes galactose as a minimal binding determinant, 
and have been identified in many species,  including  inver- 
tebrates (15). Galectin-1 is a homodimer of 14 kD subunits. 
The precise function of galectin-1 is not known,  although 
it has been shown to mediate cell-cell (16) and cell-substrate 
(17, 18) adhesion,  apparently by bridging glycoconjugate mol- 
ecules on opposing surfaces.  A role for the murine thymic 
galectin-1  in thymocyte interactions  was suggested by the 
finding  that  extracts  of murine  thymic stroma containing 
galectin-1 were shown to agglutinate immature, but not ma- 
ture, routine thymocytes (9). This observation suggested that 
specific oligosaccharide sequences on immature thymocytes 
might be ligands for galectin-1 synthesized by thymic stromal 
cells. In this regard, we have recently demonstrated that ex- 
pression of a glycosyltransferase enzyme is regulated during 
thymocyte maturation (19), suggesting that specific thymo- 
cyte cell surface oligosaccharides  have unique  functions  at 
different points  in thymocyte development. 
We wished to determine whether galectin-1 was present 
in human  thymus,  and to examine the physiologic role of 
galectin in cell-cell interactions in the thymus. We have de- 
tected galectin-1 mRNA and protein in human thymic epi- 
thelial cells. Galectin-1 appeared to mediate the adhesion of 
immature T  lymphoblastoid cells to thymic epithelial cells, 
by binding to otigosaccharide ligands on the T  cells. Anti- 
body inhibition studies indicated that some of these ligands 
are O-glycans on specific T  cell glycoproteins, the presence 
of which we have shown is developmentally regulated. These 
results indicate that carbohydrate-mediated adhesion may par- 
ticipate in the cell-cell interactions  that mediate thymocyte 
maturation.  Furthermore,  these data suggest that  these in- 
teractions are regulated by developmentally restricted expres- 
sion of oligosaccharide  ligands  on thymocytes. 
Materials and Methods 
Antibodies and Reagents.  The T305 antibody (20) was the kind 
gift of Dr. Robert Fox (Scripps Clinic and Research Foundation, 
LaJolla, CA). Murine mAbs to cytokeratin, CD43 (DF-T1), CD45-T 
(2Bll),  CD45RO  (UCHL1),  CD45RA  (4KB5),  CD45RB 
(PD7/26), and CD3 (UCFIT-1) were obtained from Dako Corp. 
(Carpinteria,  CA). The murine  mAb MFIM4 (LFA-lce, CDlla) 
was obtained from Amac Inc. (Westbrook, ME). The anti-galectin-1 
polyclonal rabbit  antiserum  was obtained  as described in  (21). 
Galectin-1 cDNA and purified, recombinant  galectin-1 expressed 
in Escherichia coli were obtained as described in (21). Biotinylated 
galectin-1 for flow cytometry experiments was prepared by coup- 
ling N-hydroxysuccinimide-biotin (Bethesda Research Laboratories, 
Gaithersburg,  MD) to recombinant  galectin-1, according to the 
manufacturer's instructions.  Mono- and disaccharides, E. coli exo- 
/~-galactosidase and Vibrio cholerae neuraminidase were purchased 
from Sigma Chemical Co. (St. Louis, MO). The Pasturella haemolytica 
O-sialoglycoprotease  was the kind gift of Dr. Alan Mellors (Univer- 
sity  of Guelph,  Canada).  [3FI]Thymidine was purchased  from 
Amersham Corp.  (Arlington  Heights,  IL). 
Cells and Tissue Samples.  Normal human thymus specimens  were 
obtained from infants and children undergoing  corrective cardiac 
surgery at UCLA Hospital. To obtain thymocytes, the tissue was 
minced, and the cells were collected and passaged over nylon wool 
to remove adherent cells and debris. The single cell suspension was 
maintained for up to 24 h at 37~  in serum-flee medium as previ- 
ously described (22). Primary cultures of human thymic epithelial 
cells were grown exactly as described by Singer et al. (23). 
Immunofluorescence and Iramunohistochemistry.  Thymus specimens 
were fixed in 4% paraformaldehyde for 24-72 h at 4~  and em- 
bedded in paraflfin. For analysis ofgalectin-1 expression, 6-/~m sec- 
tions were incubated with polyclonal rabbit antiserum to galectin-1, 
diluted 1:1,000 in 0.01 M sodium phosphate, 0.15 M NaCI,  1% 
BSA, pFi 7.5 (PBA)  1 overnight at 4~  Control sections were in- 
cubated with immune rabbit serum which had been absorbed on 
galectin-l-Sepharose  beads, at a final dilution  of 1:1,000 in PBA. 
The sections were washed three times with PBA, and incubated 
with a goat anti-rabbit  reagent conjugated to horseradish peroxi- 
dase (HRP; Bio-Rad Laboratories, Richmond, CA), diluted 1:1,000 
in PBA, for 2 h at room temperature.  Bound antibody was de- 
tected by the addition of the chromogenic substrate AEC (3-amino, 
9-ethylcarbazole) (Peroxidase Chromogen kit; Biomeda, Foster City, 
CA),  and slides were counterstained with hematoxylin.  For im- 
munofluorescence studies, the above protocol was followed, except 
that the thymus sections were hbded simultaneously with the rabbit 
anti-galectin-1 antiserum and a murine mAb to cytokeratin. Bound 
primary antibodies were detected with a goat anti-rabbit  reagent 
conjugated to FITC, diluted 1:100 in PBA, and a goat anti-mouse 
reagent conjugated to rhodamine (TRITC), diluted 1:100 in PBA 
(Tago Inc., Burlingame,  CA). 
For analysis of T305 binding, cryostat sections (6/~m) of fresh- 
frozen human thymus were fixed in  - 20~  methanol for 5 min, 
preincubated in PBA for 20 min,  and then incubated for 2 h at 
room temperature with the T305 antibody. After washing with 
PBA,  the  sections  were  incubated  in  FIRP  conjugated  goat 
anti-mouse Ig (Bio-Rad Laboratories) diluted 1:1,000 in PBA for 
2 h at room temperature. Bound antibody was detected with AEC. 
Western Analysis.  Thymic  stroma,  obtained  after removal of 
thymocytes, was extracted by homogenization  in lysis buffer (10 
mM Tris, pFi 7.3, 130 mM NaC1, 5 mM CaC12, 0.5% NP-40). 
Cultured thymic epithelial cells and MOLT-4 cells were lysed by 
brief vortexing in lysis buffer. Nuclei were removed by centrifuga- 
tion for 2 min at top speed in a microcentrifuge (model 5415; Ep- 
pendorf North America, Inc., Madison,  WI),  50 #g of protein 
were loaded on SDS-PAGE gels, along with 4/~g of purified recom- 
binant galectin-1, and electrophoresed under reducing conditions. 
Western blot analysis was performed exactly as previously described 
(21) using  the polyclonal rabbit  anti-galectin  antiserum  diluted 
1:1,000 in PBS containing  1% nonfat dry milk. 
Northern  Analysis.  Total RNA was prepared from  cultured 
thymic epithelial cells  by the guanidinium/thiocyanate method (24). 
Analysis was performed as previously described (19), using a 311- 
bp EcoR1 restriction  fragment  of human galectin-1 (21) labeled 
with c~-[32p]dCTP by random priming  (Amersham). 
Binding Assays and Inhibition Studies.  1 d before the binding assay, 
the cultured thymic epithelial cells were passaged  into 24-well  plastic 
dishes (Costar Corp.) at a density of 5  x  10  s cells/well in the ab- 
sence of the 3T3 feeder cells. This step was performed to ensure 
that there would be no contamination  of the cells with galectin-3 
synthesized by the 3T3 cells (15). MOLT-4 cells were labeled over- 
night  with  [3Fi]thymidine (50  #Ci/2  x  106 cells) in  RPMI 
(GIBCO BRL, Gaithersburg, MD) containing  10% heat-treated 
FCS and 10 mM Hepes. After labeling, the cells were washed into 
1 Abbreviations used in this paper: HRP, horseradish peroxidase; PBA, PBS 
plus albumin. 
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and resuspended at 10  s cells/ml. 5  x  104 MOLT-4 cells were added 
to the wells containing the thymic epithelial cells and were allowed 
to bind for the indicated time at either  4 or 37~  The nonad- 
herent cells were removed by gentle pipetting (sample A). The wells 
were washed three times with binding  medium,  and the washes 
were collected (sample B). The adherent cells were sohbilized by 
the addition of 1 ml of 0.5 N NaOH (sample C). The nonadherent 
cells, the washes, and the adherent cells were mixed with 1 ml of 
Ecoscint (National  Diagnostics,  Inc., Atlanta,  GA) and counted 
in  a  liquid  scintillation  counter  (Beckman  Instruments,  Inc., 
Fullerton, CA). The percentage of counts per minute bound was 
calculated as counts per minute (sample C)/[cpm (sample A)  + 
cpm (sample B)  +  cpm (sample C)]. 
In the saccharide inhibition  studies, the thymic epithelial cells 
were preincubated for 30 min with 500 #1 of a 20 mM solution 
of the indicated sugar in binding medium.  The labeled MOLT-4 
cells were added in 500 #1 of binding  medium,  so that the final 
saccharide concentration  was 100 mM. For the enzyme treatment 
studies, 104 labeled MOLT-4 cells were incubated with 25 mU of 
V. ckolerae neuraminidase alone or in combination  with 9 mU of 
E. coli exo-~-galactosidase in HBSS for 2 h at 37~  Alternatively, 
104 MOLT-4 cells were incubated with 800 #g of P.. kaemolytica 
O-sialoglycoprotease for 30 min at 37~  After enzyme treatment, 
the cells were washed into binding medium, and used in the binding 
assay. 
For antibody inhibition  studies, the labeled MOLT-4 ceUs were 
resuspended in binding medium containing the indicated antibody 
immediately before adding the MOLT-4 cells to the thymic epithe- 
lial ceils, mAbs were used at a final concentration  of 5 #g/m1. 
The rabbit  antiserum  to galectin-1 was passaged over a protein 
A-Sepharose column to obtain the Ig fraction. This preparation, 
anti-galectin-1 Ig, was used at a final concentration  of 100 #g/ml. 
Control samples contained irrelevant isotype-matched routine mAbs 
or preimmune  rabbit  antiserum. 
Flow Cytornet~  5  x  10  s cells were incubated with biotin- 
galectin-1 (50/~g/100/~1) for I h at 4~  in PBA. Cells were washed 
twice with PBA before staining with a 1:50 dilution of streptavidin- 
FITC (Boehringer-Mannheim,  Indianapolis, IN) or streptavidin- 
PE (Molecular Probes, Inc., Eugene, OR). After incubation  for 
1 h at 4~  the cells were washed twice and resuspen.ded in 500 
#1 PBA. Plow cytometric  analysis was performed within 1 h on 
a FACScan  |  (Becton Dickinson & Co., Mountain View, CA). For 
two-color analysis, CD3 antibody directly conjugated  to the dye 
PerCP (Becton Dickinson & Co.) was added to the cells simultane- 
ously with the streptavidin-PE reagent, and the cells were washed 
and analyzed as described above. 
Thymocytes were suspended at 5  x  106 cells/ml in PBA. 100 
/~1 of cell suspension was combined with 50/~1 of the appropriate 
dilution  of DF-T1 or T305 and incubated on ice for 60 rain. The 
cells were then incubated with FITC-conjugated goat anti-mouse 
IgG for a second incubation,  and finally with PE-conjugated anti- 
CD3 or PE-conjugated mouse IgG1 for a third incubation.  Con- 
trol samples, containing  isotype-matched  irrelevant murine  anti- 
bodies, were included for each sample. After the final incubation, 
cells were washed twice with cold PBA and resuspended in PBA 
containing 1/~g/ml 7-amino-actinomycin D (7-AAD; Calbiochem- 
Novabiochem  Corp.,  La Jolla,  CA)  to discriminate  dead cells. 
Samples were incubated for 20 min at 4~  protected from light, 
before acquisition. Nonviable cells, identified by uptake of 7-AAD, 
were eliminated from the acquisition by selective gating. 
In $itu Hybridization.  Full-length  digoxigenin-labeled  RNA 
probes were prepared from pBluescript II KS- (Stratagene, LaJolla, 
CA) containing fuR-length human C2GnT eDNA (25), as previ- 
ously described (19). The C2GnT was transcribed in the antisense 
orientation,  cut with BamHI, from the T3 promoter,  and in the 
sense orientation, cut with XhoI, from the T7 promoter. Sections 
of thymus (6/~m) on acetylated glass slides were treated with pro- 
teinase K and hybridized with the digoxigenin-labeled probes ex- 
actly as previously described (19). Hybridization  was detected by 
an anti-digoxigenin/allraline phosphatase conjugate,  followed by 
12-h development with the chromogenic substrate nitroblue tetrazo- 
lium/5-bromo-4-chloro-3-indoyl  phosphate. 
Results 
Human Thyraic Epithelial Cells Express Galectin-1.  To de- 
termine whether galectin-1 was present in human thymus, 
we used a polydonal rabbit antiserum raised against recom- 
binant galectin-1 for histochemical analysis of human thymus 
(Fig.  1 A). Individual reactive cells in the thymus sections, 
which appeared to be large stromal cells, were scattered among 
the nonreactive thymocytes. The reticular  staining pattern 
seen in Fig.  1 A  suggested that  the antibody was reacting 
with antigen on stromal cell processes interdigitating among 
the thymocytes. The reactive cells were present in both the 
cortical and medullary zones of the thymus. Antiserum which 
had been preadsorbed on galectin-1  showed no reactivity with 
any thymic cells  (Fig.  1 B). 
To identify the thymic stromal cells expressing galectin-1, 
we performed double-label immunofluorescence studies. Sec- 
tions were labeled with anti-galectin-1  antiserum, detected 
with  a fluorescein-tagged reagent,  and a mAb to cytoker- 
atin, which reacts with epithelial cells, detected with a rho- 
damine-tagged reagent.  Fig.  1, C  and D  demonstrates that 
the same population  of cells bound both  the  antibody to 
cytokeratin and the antibody to galectin-1,  indicating  that 
the cells reacting with the galectin-1 antiserum were thymic 
epithelial cells. Primary cultures of thymic epithelial  cells con- 
tinued to express galectin-1.  Fig. 1 E demonstrates cell-surface 
labeling of cultured epithelial cells with antibody to galectin-1. 
Diffuse reactivity was seen on the plasma membrane, extending 
to the tips of the fine processes put out by these cells in culture. 
Immunoreactive  galectin-1  was identified  in  extracts  of 
thymic stroma and of cultured thymic epithelial cells (Fig. 
2 A). A single 14-kD band was present in lanes containing 
the extracts,  which comigrated with recombinant galectin-1. 
In the lane containing recombinant galectin-1, a faint band 
of 28 kD was present, which corresponds to the homodimer 
of galectin-1;  since the subunits self-associate  by hydrogen 
bonding,  but not by formation of cysteine bonds (26),  the 
dimeric form persists in reducing  gels. 
Northern analysis of mRNA isolated from cultured human 
thymic epithelial cells demonstrated a single band of *700 
bp (Fig.  2 B). This transcript is identical in size to that en- 
coding the placental gelatin-1 (21). No other bands were de- 
tected on Northern analysis, indicating that no other rdated-14 
kD lectins,  such as galectin-2  (13),  were expressed by the 
thymic epithelial cells. These results demonstrated that human 
thymic epithelial cells expressed galectin-1 in vivo, and con- 
tinued to express galectin-1 mRNA and protein in culture. 
879  Baum  et al. Figure  1.  Expression  of galectin-1  by human  thymic  epithelial  cells. (A and B) Sections  of human  thymus  were  incubated  with either  rabbit antiserum 
to galectin-1 (.4) or with rabbit antiserum  to galectin-1 that had been preadsorbed on galectin-l-Sepharose  beads (B). Bound  antibody  was detected 
by the addition of a goat anti-rabbit Ig reagent conjugated  to HRP, which yields a brown reaction product. The slides were counterstained  with 
hematoxylin.  (C and D) Sections of human thymus  were incubated  with either a murine mAb to cytokeratin  (C) to label epithelial cells, or rabbit 
anti-galectin-1 antiserum  (D). Bound  antibody  was detected  with either goat anti-mouse  Ig conjugated  to FITC (C) or goat anti-rabbit Ig conjugated 
to TRITC (D). Coincident  staining  patterns were observed, indicating  that the cells which expressed galectin-1 were epithelial cells. (E) Primary 
cultures of human thymic  epithelial cells continued  to express galectin-1. Nonpermeabilized  cells grown on cover slips were incubated  with rabbit 
antiserum to galectin-1, and bound antibody  was detected  with goat anti-rabbit Ig conjugated to HRP. 
T  Lymphoblastoid Cells Bind  to  Thymic Epithelial  Cells in 
a  Carbohydrate-dependent Manner.  To  examine the  role  of 
galectin-1  in the interaction of thymic epithelial cells with 
developing T cells, we established a binding assay which mea- 
sured the binding of a T lymphoblastoid cell line MOLT-4, 
labeled  with  [3H]thymidine, to cultured thymic epithelial 
cells (Fig. 3). Labeled MOLT-4 cells were incubated with the 
adherent thymic epithelial cells for increasing periods of time 
at 37~  and 4~  As shown in Fig. 3, '~75% of the MOLT-4 
cells bound to the epithelial ceils at 37~  binding was also 
observed  at 4~  although a smaller percentage of the ceils 
bound at this temperature. At both temperatures, half-maximal 
binding occurred by 30 min of incubation, and binding reached 
maximum by 60--90 min of  incubation. In contrast, only 11% 
oflabded BJAB ceils, a B lymphoblastoid cell line, were bound 
to the epithelial cells by 90 min at 37~  The addition of 
EGTA (2 raM) to the binding assay had no inhibitory effect 
on binding, indicating that divalent cations were not required 
for binding (data  not shown). 
The binding of MOLT-4 cells to the thymic epithelial ceils 
was inhibited by/~-galactosides, but not by other simple sugars 
(Fig. 4). The addition of lactose and thiodigalactoside inhibited 
binding by 69 and 49%, respectively.  The inhibitory effect 
of the/~-galactosides was detectable at concentrations as low 
as 25 mM (data not shown). No significant inhibition was 
seen with the other saccharides tested. The inhibitory effects 
of the ~-galactosides,  as well as the absence of inhibition by 
EGTA, suggested that the carbohydrate-mediated adhesion 
which we observed  was mediated by a galectin. 
To characterize  the T  cell surface oligosaccharide ligands 
involved  in binding to  thymic epithelial cells,  the labeled 
MOLT-4 cells were treated with a panel of glycosidase en- 
zymes before binding (Fig.  5). Treatment of the cells with 
V. cholerae neuraminidase resulted in an increase in binding, 
suggesting that sialic acid residues on T cell surface oligosac- 
charides  might be masking ligands that could bind to the 
epithelial  cells. Alternatively, removal of negatively charged 
sialic acid residues from the T  cell surface may have poten- 
880  Galectin-mediated  Adhesion in the Thymus Figure 2.  Immunoreactive  material  in human  thymic  epithelial  cells  is 
galectin-1. (A) Extracts of human thymic  stroma, from which the thy- 
mocytes  were  expressed,  and of cultured  thymic  epithelial  cells were  ana- 
lyzed  by Western  blotting for expression  of galectin-1. In these samples, 
a band  of 14 kD is seen  that comigrates  with recombinant  galectin-1  (Gal- 
l). MOLT-4  cells, the cells  used  in binding assays  described  below, did not 
express galectin-1. (B) PolyA  + RNA was prepared  from cultured  human 
thymic  epithelial  cells  and was subjected  to Northern  analysis  using  a frag- 
ment of galectin-1  cloned  from human  placenta  (27) as a probe. A single 
band of ",, 700 bp was detected. 
tiated binding by reducing charge repulsion between T cells 
and thymic epithelial cells. In contrast, when the cells were 
incubated with a combination of neuraminidase and E.  coli 
exo-B-galactosidase,  to remove terminal galactose residues, 
binding was  significantly decreased, to  ",~34% of control. 
These results indicated that galactose residues on T cell sur- 
face glycoproteins participated in the binding of the MOLT-4 
cells to  the thymic epithelial cells. 
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Figure 3.  [3H]Thymidine-labeled  MOLT-4 cells bind  to  cultured 
human thymic  epithelial  cells. Labeled  cells  were  incubated  with epithelial 
cells (ratio 1:10) for the indicated  times  at either  4~  (open  circles)  or 37~ 
(closed  diamonds). As a control, the binding  of  the B cell  line  BJAB  at 37~ 
is shown  (closed  square). The percentage  of added cpm bound was deter- 
mined. The data are expressed  as the mean  of three separate  experiments, 
each performed  in duplicate, _+  SEM. 
To begin to characterize the oligosaccharide structures on 
the T  cells  that were participating in binding,  the labeled 
MOLT-4 cells were treated with P. haemolytica  O-sialogly- 
coprotease. This enzyme has been shown to be effective in 
removing a variety of O-linked oligosaccharide epitopes from 
T cell surface antigens (27). Treatment of the MOLT-4 cells 
with  the O-sialoglycoprotease reduced binding by "~50% 
(Fig.  5).  These data indicated that T  cell surface glycopro- 
teins bearing O-linked oligosaccharides were at least a subset 
of the ligands involved in carbohydrate-mediated binding of 
the T  cells  to  thymic epithelial cells. 
Antibody  Inhibition  Studies  Indicate  that  Two Major  T  Cell 
Glycoproteins Are Ligandsfor Galectin-1.  Figs. 4 and 5 demon- 
strated that the carbohydrate-mediated binding of MOLT-4 
cells to thymic epithelial cells involved galactose residues on 
the T cells and was inhibitable by ~-galactosides, suggesting 
that a galectin was involved in binding.  We examined the 
ability of  an  ti-galectin-1 Ig to inhibit the binding of  MOLT-4 
cells to thymic epithelial cells.  Addition of anti-galectin-1 
Ig to the binding assay inhibited the binding of MOLT-4 cells 
to thymic epithelial cells by '~,50%,  compared with control 
samples containing preimmune rabbit Ig (Fig.  6). Since we 
did not detect galectin-1 in MOLT-4 cells by Western blbt 
analysis (see Fig.  1), these results suggested that galectin-1 
on thymic epithelial cells bound to oligosaccharides on the 
surface  of MOLT-4 cells. 
To identify the T  lymphoblastoid cell surface glycopro- 
teins that bound to galectin-1 on epithelial cells, we proposed 
that two T cell surface glycoproteins, CD43 and CD45, might 
be candidate ligands for galectin-1.  Whereas the minimal 
oligosaccharide recognition structure recognized by galectin-1 
may be present on a number of T cell surface glycoproteins, 
it is likely that only a small number of specific glycoproteins 
are  the biologically relevant ligands  for  galectin-1  in  the 
thymus, as has been shown for the selectins (28).  The large 
body of data describing structural features of T  cell surface 
antigens  indicated  that  CD43  (leukosialin)  and  CD45 
(common leukocyte antigen) have oligosaccharide sequences 
that could be ligands for galectin-1. Both of these molecules 
have large extracellular domains that are heavily O-glycosylated 
(29),  and the enzyme treatments described in Fig.  5 indi- 
cated that O-glycans might be recognized by galectin-1 on 
thymic epithelial cells. In addition, carbohydrate analyses of 
CD43 and CD45 have demonstrated that both of these mol- 
ecules can bear poly N-acetylactosamine sequences,  the oli- 
gosaccharide sequence preferentially recognized by galectin-1, 
on O-linked oligosaccharides (28,  30,  31). 
mAbs against both CD43 and CD45 inhibited the binding 
of MOLT-4 cells to thymic epithelial cells (Fig.  6). We first 
observed that a mAb cocktail which recognizes all isoforms 
of CD45 inhibited binding by m44% (CD45, Fig.  6). This 
reagent is composed of two mAbs, PD7/26 and 2Bll. When 
we assayed these antibodies separately for the ability to in- 
hibit binding, only the 2Bll  antibody, which recognizes a 
T cell-specific isoform of CD45 (32), inhibited the binding 
of MOLT-4 cells. Antibody to CD45RB  alone (PD7/26), 
as  well  as  other  antibodies  against  the  CD45  isoforms 
CD45RO and CD45RA, had no significant effect on MOLT-4 
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Figure  4.  /3-galactosides  inhibit the binding of MOLT-4 
cells to  thymic epithelial cells.  [3H]Labeled  MOLT-4  cells 
were incubated with epithelial cells for 90 min at 37~  in 
the presence of the indicated saccharides  at a final concentra- 
tion of 100 mM.  The added saccliarides  were fucose (fuc), 
galactose (ga/),  mannose (man), thiodigalactoside (thio), lac- 
tose  (/at),  N-acetylgalactosamine  (Ngal),  and  N-acetyl- 
glucosamine (Ngk). The bound cpm was determined for each 
sample, and binding was calculated as the percentage of the 
cpm bound in the control samples containing no saccharides. 
The data are expressed as the mean of two separate  experi- 
ments,  each performed in duplicate,  +  SEM. 
binding. Although the precise structure of the epitope  rec- 
ognized by the 2Bll  antibody is not known, these results 
suggested that the specific epitope recognized by 2Bll par- 
ticipates in the binding of the MOLT-4 cells to the epithelial 
cells.  The inhibitory effect of the 2Bll  antibody appeared 
to be augmented by the addition of the PD7/26 antibody, 
which may  have contributed to blocking the determinant 
bound by the epithelial  cells. 
The T305  antibody to CD43  also inhibited binding of 
MOLT-4 cells by '-45%. The T305 antibody (20) is known 
to recognize core 20-glycans on CD43 (25). Another CD43 
antibody, DF-T1, which recognizes CD43 on all thymocytes 
and T cells,  had a more modest inhibitory effect,  reducing 
binding by "28% (CD43, Fig. 6). The inhibitory effect of 
the T305 antibody suggested that core 20-glycans on CD43 
participated in the binding of MOLT-4 cells to thymic epi- 
thelial  cells. 
Combining the rabbit antibody to galectin-1  with either 
the T305 or 2Bll antibodies again resulted in "50% inhibi- 
tion of binding. Since no additive effect over the inhibition 
observed with the anti-galectin-1 Ig alone was detected, the 
inhibitory effect  of the T305  and 2Bll  antibodies  on the 
binding of MOLT-4 cells to thymic epithelial cells was most 
likely due to disruption of the binding of CD43 and CD45 
on the T  cells  to galectin-1  on the epithelial  cells. 
Galectin-1 Binds to Human Tkymocytes.  Our evidence in- 
dicated that  galectin-1  on thymic epithelial  cells bound to 
cell surface oligosaccharides  on MOLT-4 T lymphoblastoid 
cells. To directly examine the ability of thymocyte and T lym- 
phoblastoid cells  to bind galectin-1,  we developed  a flow 
cytometry  assay in  which  cells  were  incubated  with  bi- 
otinylated recombinant  galectin-1,  and bound lectin was de- 
tected with streptavidin-FITC.  Fig. 7 A  demonstrates  that 
the MOLT-4 cells uniformly bound high levels of galectin-1. 
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Figure  5.  The effects of glycosidase treatment on the binding of MOLT-4 
cells  to thymic epithelial cells.  [3]H-Labeled  MOLT-4 cells were treated 
with V. cholerae neuraminidase  alone (n'ase), with a combination of V. cholerae 
neuraminidase and E. coli /3-galactosidase  (n'ase + gal'ase) or with P. kae- 
molytica O-sialoglycoprotease (O-SGP), or were mock-treated by incuba- 
tion in buffer alone. The cells were added to the thymic epithelial cells 
for 30 min at 4~  and the percentage of cpm bound of the treated cells 
was compared with that of the control, mock-treated cells. The data are 
expressed as the mean of three separate  experiments, each performed in 
duplicate,  -+  SEM. 
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Figure  6.  Ability of antibodies to galectin-1 and T  cell surface glyco- 
proteins to inhibit binding of MOLT-4 cells to thymic epithelial cells, mAbs 
to LFA-1, CD43,  and CD45,  (final concentration,  5 Izg/ml), or protein 
A  affinity-purified rabbit antibody to galectin-1 (gal-l)  (final concentra- 
tion, 100 #g/ml) were added to the MOLT-4 cells immediately before ad- 
dition of the cells to the thymic epithelial cells.  Binding was performed 
for 90 min at 4 ~  C. The percentage of cpm bound of the antibody-treated 
cells was compared with that of control samples. The data are expressed 
as the mean of two separate experiments,  each performed in duplicate, 
_+ SEM, except for the gal-1 antibody and T305 antibody samples, which 
are the mean of three separate  experiments. 
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Figure 7.  MOLT-4 cells and 
human thymocytes  bind galectin-1. 
Cells were  labeled  with biotinylated 
galectin-1,  followed by  either 
streptavidin-FITC (A)  or  strep- 
tavidin-PE (B and C), and analyzed 
by flow  cytometry.  (A) Single-color 
analysis of MOLT-4 cells labeled 
with biotinylated galectin-1 (solid 
line) or biotinylated BSA as a con- 
trol (broken line). (B) Single-color 
analysis of freshly isolated human 
thymocytes labeled with biotiny- 
lated galectin-1 (solid line) or bi- 
otinylated BSA as a control (broken 
line).  (C)  Two-color analysis of 
freshly isolated human thymocytes 
labeled with biotinylated galectin-1 and a murine mAb to CD3, directly  conjugated to PerC1  ~. Gates  were set using biotinylated  BSA and streptavidin- 
PE on the y-axis, and an isotype-matched  murine antibody  conjugated to PerC1  ~  on the x-axis. The experiment shown is representative of five separate 
experiments using different thymus specimens. 
Binding was completely inhibited when the galectin-1 was 
preincubated with lactose before addition to the MOLT-4. 
Using this flow cytometry assay, we found that  human 
thymocytes also bound galectin-1.  When unseparated thymo- 
cytes were analyzed using this method, the majority of the 
cells bound high levels of galectin-1, whereas a small popula- 
tion of cells bound lower levels of galectin-1 (Fig. 7 B), sug- 
gesting that the availability  of galectin-1 ligands might differ 
among  thymocyte subpopulations.  To relate the degree of 
galectin-1 binding to the stage of thymocyte maturation, we 
performed  dual-color  flow  cytometric  analysis,  using  bi- 
otinylated  galectin-1  and  PerCPTM-conjugated  CD3.  Fig. 
7 C  demonstrates  that  immature  CD3-  and CD3  ~m cells 
uniformly bound  high  levels  of galectin-1,  (relative linear 
fluorescence intensity  =  337 [33]). In contrast,  the mature 
CD3  b~ight cells bound slightly less galectin-1,  (relative linear 
fluorescence intensity  =  217). The difference in binding did 
not appear to be due to occupation of binding  sites by en- 
dogenous galectin-1 which remained bound to the thymo- 
cytes during the cell purification and binding assay, since we 
did not detect any endogenous galectin-1 bound to the cells 
by flow cytometric analysis using rabbit antiserum to galectin-1 
(Wu, T., and L. G. Baum, unpublished data). These results 
demonstrated that thymocytes expressed cell surface oligosac- 
charide ligands for galectin-L These results also indicated that 
the ability of thymocytes to bind galectin-1 decreased slightly 
as the cells  acquired a mature  T  cell phenotype. 
CD3-  and  CD3 dim  Thyraocytes  Express  the  T305  An- 
tigen.  Our antibody inhibition studies indicated that some 
of the oligosaccharide ligands on the MOLT-4 cells which 
appeared to bind to galectin-1 were core 20-glycans on CD43, 
recognized by the T305 antibody. To identify the subsets of 
thymocytes that express the T305 antigen, we performed two- 
color flow cytometric analysis using T305 and CD3 mAbs. 
CD3-  and CD3  ~m thymocytes bound high levels of the 
T305  antibody (Fig.  8 A).  In contrast,  the CD38ng  h~ cells 
demonstrated no binding of T305 above background levels. 
The increased level of binding of the T305 antibody by the 
CD3-  and CD3  ~  cells was not due to differences in the 
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level of expression of the CD43 polypeptide. Two-color analysis 
of the thymocytes using CD3 and the DFT1 antibody, which 
recognizes CD43 on all thymocytes and T cells, demonstrated 
equivalent levels of staining of all three populations (Fig. 8 B). 
These results indicated that the high level of T305 binding 
to the immature  (CD3-  and CD3 arm) thymocytes, but not 
to  the  mature  (CD3b~ig  ht)  thymocytes,  was related  to  the 
presence or absence of the core 20-glycans on CD43, and 
not to a difference in the level of expression of the CD43 
protein backbone. 
The Level of C2GnT Expression  Correlates with the Presence 
of the T305 Antigen  in the Thymic Cortex.  We performed 
immunohistochemical  staining of sections of thymus with 
the T305 antibody (Fig. 9). As predicted from the flow cyto- 
metric analysis, cells in the subcapsular cortex and the cortex 
stained strongly with the T305 antibody (Fig.  9, B and C). 
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Figure 8.  Expression  of CD43 bearing core 20-glycans on popula- 
tions of freshly isolated human thymocytes. Thymocytes  were analyzed 
by two-color flow cytometry, using either the DFT1 (CD43) antibody 
or the T305 antibody phs goat anti-mouse-FITC, and CD3-PE. CD3 
staining identifies CD3-, CD3  dlm (CD3/~ and CD3h~  ht (CD3  h') cells, 
which correspond to increasingly mature thymocyte  subpopulations. (,4) 
Fluorescence intensity (on a log scale) of staining with T305 antibody 
to core 20-glycans on CD43 (horizontal  axis) vs. CD3 (vertical  axis). The 
gate was set using FITC-conjugated, isotype-matched  control mouse IgG. 
(B) DFT1 vs. CD3. Figure  9.  Comparison  of T305 reactivity  and C2GnT expression in human thymus.  Serial sections of thymus  were reacted  with either the T305 
antibody, detected  with goat anti-mouse  conjugated to HRP, or with digoxigenin-labeled  RNA antisense probe to the C2GnT enzyme, detected 
with antidigoxigenin  antibody  conjugated  to alkaline  phosphatase. The cortical (C) and medullary  (/14) regions of the thymus  are indicated  on each 
panel. (A) Control antibody  staining  with isotype-matched  mouse Ig. (B and C) Staining with the T305 antibody  (xl00 and x400). (D) Control 
in situ hybridization  with sense orientation  C2GnT probe. (E and F) In situ hybridization  with antisense orientation  C2GnT probe (xl00 and x400). 
These cells are typically CD3-  and CD3  cam, respectively. In 
contrast,  only scattered  cells in  the medulla,  where most 
thymocytes are CD3brig  ht, reacted with the T305 antibody. 
Fig. 9 C demonstrates that the antibody staining is seen pri- 
marily on the cell surface, although intracellular staining is 
seen in a few cells. The intraceUular staining most likely results 
from the T305 antibody binding to core 2-containing CD43 
molecules  still in the secretory pathway, which are exposed 
by tissue sectioning. No specific staining was seen in sections 
incubated with  an  isotype-matched control  murine  mAb 
(Fig.  9 A). 
The presence of the T305 antigen on the cell surface gly- 
coprotein CD43 results from expression of the C2GnT (25), 
suggesting that cells which bind T305 may have a higher 
level of expression  of the C2GnT enzyme. To relate the pat- 
tern of T305 binding to expression of the C2GnT in human 
thymus, we performed in situ hybridization on serial sections 
of thymus tissue,  using an antisense RNA probe  for  the 
C2GnT.  The pattern of expression  of the C2GnT in the in 
situ hybridization analysis correlated exactly with the T305 
immunohistochemical staining pattern (Fig.  9 E).  Cells  in 
the subcapsular  cortex and the cortex demonstrated strong 
reactivity with the antisense probe, as shown by the darkly 
stained cells in these regions, whereas most cells in the medulla 
demonstrated only faint reactivity. Fig. 9 F shows the strong 
cytoplasmic signal detected in the cortical cells with the C2GnT 
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probe for the C2GnT, showed no hybridization signal (Fig. 
9 D). The correlation between T305 antigen expression and 
C2GnT expression indicates that developmentally regulated 
expression of the C2GnT enzyme accounts for the presence 
of core 20-glycans on immature thymocytes. 
Discussion 
The present study demonstrates that cell surface oligosac- 
charides on immature T cells mediate adhesion of these cells 
to thymic epithelium, at least in part via the endogenous ep- 
ithelial cell lectin galectin-1. Our laboratory and others have 
documented the complex changes in thymocyte cell surface 
glycosylation which occur during thymocyte maturation (19, 
34-36).  The precise regulation of oligosaccharide synthesis 
during T cell development suggests that different oligosac- 
charide sequences have unique functions at specific points in 
thymocyte maturation. However, no study has directly demon- 
strated a role for thymocyte cell surface oligosaccharides in 
cell-cell interactions. 
Galectins have been proposed to participate in fetal devel- 
opment (37), in the migration of myoblasts on laminin (17, 
18), in regulation of cell growth (38-40),  and in tumor cell 
adhesion and metastasis (16, 41). Homodimeric galectin-1 ap- 
pears to mediate cellular adhesion by binding to glycopro- 
tein ligands on apposing cells or on cells and extracellular 
matrix components, bridging these structures.  In different 
tissues, specificity of galectin-mediated  interactions  may re- 
sult from the selective expression of different glycoprotein 
ligands  in the tissues (42).  Our data,  demonstrating that 
galectin-1 on human thymic epithelial cells binds to thymo- 
cytes bearing the appropriate oligosaccharide ligands, is the 
first report of a role for galectin-1 in lymphocyte development. 
Fig. 4 demonstrates that ~-gahctosides inhibited the binding 
of MOLT-4 cells to thymic epithelium. The requirement for 
millimolar concentrations of simple sugars for inhibition of 
binding is a common feature of lectin-ligand interactions in 
complex biological systems. This reflects the fact that, whereas 
a simple saccharide structure may be the minimal recogni- 
tion structure bound by most animal lectins, the physiologic 
ligands bound by these lectins are more complex,  and are 
typically specific glycoproteins which bear multiple saccha- 
ride structures  (42). 
The T cell surface ligands recognized by galectin-1 include 
glycoproteins bearing O-glycans, since O-sialoglycoprotease 
treatment of the T cells significantly reduced binding of the 
cells to thymic epithelium (Fig. 5). Additional oligosaccha- 
ride ligands may be N-glycans, which can also bear the poly- 
N-acetyllactosamine sequences preferentially bound by S-type 
lectins (18, 42). The two T cell surface glycoproteins which 
we identified as candidate ligands for galectin-1, CD43 and 
CD45, were examined because these are extensively O-gly- 
cosylated molecules with mucinlike domains (29). Both of 
these molecules have been shown to acquire carbohydrate 
differentiation antigens during thymocyte development (34- 
36, 43) and poly-N-acetyllactosamine sequences, the oligosac- 
charide structures preferentially recognized by galectin-1, have 
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been identified on both CD43 and CD45 (30, 31). Adhesive 
(44, 45) and antiadhesive (46, 47) properties  of CD43 and 
CD45  have been demonstrated, although the role of the 
oligosaccharides in these functions is not clear. 
Antibodies to galectin-1, as well as specific antibodies to 
CD43 and CD45, blocked binding of MOLT-4 cells to thymic 
epithelial cells (Fig. 6). The epitope recognized by the T305 
antibody,  the core 20-glycan on CD43, is created by ex- 
pression of a specific N-acetylglucosaminyltransferase  (core 
2 GnT) which initiates formation of the branch to which the 
lactosamine unit is added (25). Inhibition by the T305 anti- 
body suggested that galectin-1 bound to core 20-glycans 
on  CD43,  perhaps  via  the lactosamine  sequences on  the 
oligosaccharide chains. In all cases, the maximal level of anti- 
body inhibition that we observed was '~50%. This level of 
inhibition of T cell-epithelial cell binding is similar to that 
reported in other systems, in which antibodies to thymocyte 
cell surface molecules such as integrins were demonstrated 
to block binding (48). This may indicate that multiple adhe- 
sion systems participate in cell-cell binding in in vitro assays. 
To minimize some of these other interactions, we performed 
the binding assays at  4~  a temperature at  which LFA- 
1/ICAM-l-mediated binding of thymocytes or T lympho- 
blastoid cells is inhibited in vitro (48). As shown in Fig. 6, 
antibody to the ot subunit of LFA-1 had a minimal inhibi- 
tory effect on binding. In addition, the MOLT-4 cell line 
used for this study does not express cell surface CD2 (Uit- 
tenbogaart, C.H., unpublished data), which is known to par- 
ticipate in thymocyte adhesion  (1). 
Antibodies to CD43 have been shown to cause shedding 
of the molecule  from the cell surface (49). We examined 
whether binding of galectin-1 would mimic this effect, by 
incubating MOLT-4 cells with galectin-1 and then examining 
cell surface CD43  expression  after  dissociation  of bound 
galectin-1 with lactose. We have found no decrease in cell 
surface levels of CD43 on MOLT-4  cells after binding of 
galectin-1 (Giese, M., and L.G. Baum,  unpublished data). 
Flow cytometric analysis of galectin-1 binding to thymo- 
cytes demonstrated that thymocytes bound galectin-1, with 
immature thymocytes binding slightly more galectin-1 than 
mature thymocytes (Fig. 7). This pattern of binding is similar 
to the pattern of binding of the T305  antibody to human 
thymocytes. Figs. 8 and 9 demonstrate that the presence of 
core 20-glycans, detected by the T305 antibody, as well as 
the expression of the core 2 GnT, are regulated during thymo- 
cyte development,  with the highest level of expression seen 
in immature cortical thymocytes. These results suggest that 
the degree of binding of thymocyte glycoproteins to galectin-1 
on epithelial cells may be regulated by controlling the syn- 
thesis of the oligosaccharide ligands during thymocyte de- 
velopment.  According to this model, regulated expression 
of glycosyltransferase  enzymes, such as the core 2 GriT, would 
create cell surface oligosaccharides on immature thymocytes 
which would be recognized by galectin-1 on epithelial cells. 
Thymocyte maturation would be accompanied by downregu- 
lation of the glycosyltransferase enzymes, and de novo syn- 
thesis of glycoproteins lacking the oligosaccharide recogni- 
tion structures,  resulting in dissociation from galectin-1. The  importance  of endogenous  lectins  in  lymphocyte 
trafficking and cell-cell communication is becoming increas- 
ingly apparent. In addition to carbohydrate binding proteins 
such as the selectins  (28) and the B cell antigen CD22 (50), 
it appears  that galectins may also  play a role in regulating 
lymphocyte adhesion.  Other studies (51,  52) have demon- 
strated that galectins are immunosuppressive,  in animal models 
of autoimmune diseases. Whereas the full role of galectin-1 
in modulating immune function is not yet understood, the 
present study indicates that galectin-1 participates in crucial 
cell-cell interactions during T  cell development. 
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